Ampersand buys NEOMED-LABS

Ampersand Capital Partners has acquired NEOMED-LABS from the NEOMED Institute. No financial terms were disclosed. NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development.

4 September 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles